Skip to main content

Aurinia Pharmaceuticals Inc 10-Q for FY2024 Q2

Aurinia Pharmaceuticals Inc. (AUPH)

10-Q 2024-08-01 For: 2024-06-30
View Original
Added on April 04, 2026

About this 10-Q

Aurinia Pharmaceuticals Inc filed this 10-Q on August 1, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$57.19M
up 37.8% from $41.49M a year earlier
Net income
$722K
compared with a net loss of $11.49M a year earlier
Diluted EPS
$0.01
compared with -$0.08 a year earlier